Project Grant K23DK140617

Award Date 7/22/24
Completion Date 3/31/28
Dollars Obligated $191K
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Aurora, CO 80045, USA
Similar Awards
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to develop a liquid biopsy test to diagnose and stage sepsis-associated acute kidney injury (SAKI) in humans. The $472,359 award to the Trustees of Indiana University, doing business as Indiana University Indianapolis, will support research to first identify blood-based biomarkers in mice...
This $199,990 Project Grant award, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research, will support research conducted by The Ohio State University to investigate the role of the transcriptional corepressor CTBP2 as a metabolic sensor in acute kidney injury (AKI). The project will examine how CTBP2 activation, regulation, and transcriptional suppression of genes involved in...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $300,243 project grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the University of Florida. The project aims to develop personalized machine learning techniques to improve acute kidney injury (AKI) prediction and prognosis in hospital settings. Key objectives include addressing challenges in constructing individualized patient cohorts and avoiding...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $548,830.00 to Nephsmart LLC to develop and test a device for predicting the future development of severe acute kidney injury (AKI). The device aims to detect extensive cleavage of a specific protein in the urine, which preliminary data suggests is a strong predictor of severe AKI. The...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $820,119 to The Washington University to conduct research on mechanisms related to chronic kidney diseases, with a focus on glomerular diseases. The goal is to better understand the pathogenesis of glomerular diseases and identify potential therapeutic targets to improve outcomes for...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $164,040 project grant (Grant ID K08DK136914) to the University of Pittsburgh under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant aims to clarify the role of the unfolded protein response (UPR) pathway and the PERK stress sensor in acute kidney injury (AKI) using a novel mouse model. The research seeks to discern the mechanism by which PERK drives AKI...
This R01 research project grant award of $464,446 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) aims to investigate the mechanisms of acute kidney injury (AKI) caused by mechanical ventilation. The multi-disciplinary research team will conduct renal micropuncture assessments to identify the physiological changes in glomerular and tubule function that contribute to...
This federal Project Grant award, valued at $197,748.00, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant was awarded on July 25, 2024 to the University of California, San Francisco with the ultimate completion date of March 31, 2029. The project aims to improve proteinuria testing and management after acute kidney injury (AKI) through qualitative...
This Project Grant award of $400,000 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award will support research at the University of Texas Southwestern Medical Center focused on understanding the earliest stages of kidney damage in collagen IV nephropathies. The key goals are to investigate how mutant collagen IV proteins lead to early podocyte...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $200,000 to New York University School of Medicine to conduct a case-cohort study examining novel risk factors for end-stage kidney disease (ESKD) among living kidney donors. The research aims to develop improved risk prediction tools to better inform the counseling and...

This $190,932 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support research on the role of complement activation in sepsis-associated acute kidney injury (SA-AKI). The award to the University of Colorado-Denver aims to examine the association between elevated urine complement factor B and the development of SA-AKI in critically ill children and adults with sepsis. The research will prospectively enroll patients, measure longitudinal urine complement levels, and analyze complement deposition on kidney cells to elucidate the mechanisms linking complement activation and SA-AKI. This work will help identify a potential therapeutic window for future clinical trials targeting the complement cascade to prevent and treat SA-AKI in critically ill sepsis patients.

Generated 4/8/25, 3:49 AM